2024

The Clinical Translation of α-humulene – A Scoping Review
The Clinical Translation of α-humulene – A Scoping Review 280 374 Curaleaf Australia

Cannabidiol’s Cytotoxicity in Pancreatic Cancer is Induced via an Upregulation of Ceramide Synthase 1 and ER Stress
Cannabidiol’s Cytotoxicity in Pancreatic Cancer is Induced via an Upregulation of Ceramide Synthase 1 and ER Stress 250 353 Curaleaf Australia

Cannabis Use in the UK: A Quantitative Comparison of Individual Differences in Medical and Recreational Cannabis Users
Cannabis Use in the UK: A Quantitative Comparison of Individual Differences in Medical and Recreational Cannabis Users 724 1024 Curaleaf Australia

Illicit Cannabis Use to Self-Treat Chronic Health Conditions: A Cross-Sectional Study from the United Kingdom
Illicit Cannabis Use to Self-Treat Chronic Health Conditions: A Cross-Sectional Study from the United Kingdom 724 1024 Curaleaf Australia

UK Medical Cannabis Registry: A Case Series Analyzing Clinical Outcomes of Medical Cannabis Therapy for Generalized Anxiety Disorder Patients
UK Medical Cannabis Registry: A Case Series Analyzing Clinical Outcomes of Medical Cannabis Therapy for Generalized Anxiety Disorder Patients 298 397 Curaleaf Australia

Assessment of Clinical Outcomes in Patients With Inflammatory Arthritis: Analysis From the UK Medical Cannabis Registry
Assessment of Clinical Outcomes in Patients With Inflammatory Arthritis: Analysis From the UK Medical Cannabis Registry 298 397 Curaleaf Australia

Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study 200 259 Curaleaf Australia

UK Medical Cannabis Registry: A Cohort Study of Patients Prescribed Cannabis-based Oils and Dried Flower for Generalised Anxiety Disorder
UK Medical Cannabis Registry: A Cohort Study of Patients Prescribed Cannabis-based Oils and Dried Flower for Generalised Anxiety Disorder 200 261 Curaleaf Australia

UK Medical Cannabis Registry: An Updated Analysis Of Clinical Outcomes Of Cannabis-based Medicinal Products For Inflammatory Bowel Disease
UK Medical Cannabis Registry: An Updated Analysis Of Clinical Outcomes Of Cannabis-based Medicinal Products For Inflammatory Bowel Disease 200 259 Curaleaf Australia

UK Medical Cannabis Registry: A Clinical Outcome Analysis of Medical Cannabis Therapy in Chronic Pain Patients With and Without Co-morbid Sleep Impairment
UK Medical Cannabis Registry: A Clinical Outcome Analysis of Medical Cannabis Therapy in Chronic Pain Patients With and Without Co-morbid Sleep Impairment 595 782 Curaleaf Australia

©2026 CURALEAF AUSTRALIA

Privacy Policy

LEVEL 5, 126 PHILLIP STREET, SYDNEY, 2000, NSW

curaleaf.aus@curaleafint.com

For healthcare professionals only. Curaleaf Australia products are prescription-only and intended for healthcare professionals and stakeholders only. This website does not promote the use or supply of medicinal cannabis to the public. Not for public promotion or recreational use.

Back to top